AP251A - Dichloroaniline compound. - Google Patents

Dichloroaniline compound. Download PDF

Info

Publication number
AP251A
AP251A APAP/P/1991/000271A AP9100271A AP251A AP 251 A AP251 A AP 251A AP 9100271 A AP9100271 A AP 9100271A AP 251 A AP251 A AP 251A
Authority
AP
ARIPO
Prior art keywords
compound
formula
amino
solution
evaporated
Prior art date
Application number
APAP/P/1991/000271A
Other languages
English (en)
Other versions
AP9100271A0 (en
Inventor
Brian David Judkins
Brian Evans
James David Meadows
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909012465A external-priority patent/GB9012465D0/en
Priority claimed from GB919104645A external-priority patent/GB9104645D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP9100271A0 publication Critical patent/AP9100271A0/xx
Application granted granted Critical
Publication of AP251A publication Critical patent/AP251A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1991/000271A 1990-06-05 1991-06-04 Dichloroaniline compound. AP251A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909012465A GB9012465D0 (en) 1990-06-05 1990-06-05 Chemical compounds
GB919104645A GB9104645D0 (en) 1991-03-05 1991-03-05 Chemical compound

Publications (2)

Publication Number Publication Date
AP9100271A0 AP9100271A0 (en) 1991-07-31
AP251A true AP251A (en) 1993-04-20

Family

ID=26297165

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000271A AP251A (en) 1990-06-05 1991-06-04 Dichloroaniline compound.

Country Status (25)

Country Link
EP (1) EP0460924A1 (tr)
JP (1) JPH05117236A (tr)
KR (1) KR920000717A (tr)
AP (1) AP251A (tr)
AT (1) AT399874B (tr)
AU (1) AU635424B2 (tr)
BE (1) BE1005612A5 (tr)
CA (1) CA2043850A1 (tr)
CH (1) CH682322A5 (tr)
DE (1) DE4118293A1 (tr)
DK (1) DK106991A (tr)
ES (1) ES2036920B1 (tr)
FI (1) FI912679A (tr)
FR (1) FR2662691A1 (tr)
GB (1) GB2244709B (tr)
GR (1) GR1001309B (tr)
IE (1) IE911898A1 (tr)
IL (1) IL98363A0 (tr)
IT (1) IT1245868B (tr)
LU (1) LU87945A1 (tr)
MY (1) MY106672A (tr)
NL (1) NL9100960A (tr)
OA (1) OA09501A (tr)
PT (1) PT97858A (tr)
SE (1) SE500706C2 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
GB0014546D0 (en) 2000-06-14 2000-08-09 Glaxo Group Ltd A novel process
FR2960153B1 (fr) * 2010-05-20 2012-08-17 Centre Nat Rech Scient Nouveaux bras autoreactifs et prodrogues les comprenant

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536712A (en) * 1966-09-22 1970-10-27 Boehringer Sohn Ingelheim 1-(amino-dihalo-phenyl)-2-amino-ethanes and -ethanols and salts thereof
US4396627A (en) * 1979-06-16 1983-08-02 Beecham Group Limited Secondary amines, their preparation and use in pharmaceutical compositions
GB2187734A (en) * 1986-02-12 1987-09-16 Glaxo Group Ltd Dichloroaniline derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
ES8802416A1 (es) * 1986-04-15 1988-06-01 Glaxo Group Ltd Un procedimiento para la preparacion de derivados de dicloroanilina.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536712A (en) * 1966-09-22 1970-10-27 Boehringer Sohn Ingelheim 1-(amino-dihalo-phenyl)-2-amino-ethanes and -ethanols and salts thereof
US4396627A (en) * 1979-06-16 1983-08-02 Beecham Group Limited Secondary amines, their preparation and use in pharmaceutical compositions
GB2187734A (en) * 1986-02-12 1987-09-16 Glaxo Group Ltd Dichloroaniline derivatives

Also Published As

Publication number Publication date
FR2662691A1 (fr) 1991-12-06
LU87945A1 (fr) 1993-01-15
GB2244709A (en) 1991-12-11
DK106991A (da) 1991-12-06
IT1245868B (it) 1994-10-25
GR1001309B (el) 1993-08-31
BE1005612A5 (fr) 1993-11-23
IL98363A0 (en) 1992-07-15
GB9111946D0 (en) 1991-07-24
ES2036920A1 (es) 1993-06-01
AP9100271A0 (en) 1991-07-31
CA2043850A1 (en) 1991-12-06
SE500706C2 (sv) 1994-08-15
ES2036920B1 (es) 1994-02-16
FR2662691B1 (tr) 1994-04-22
ITRM910387A1 (it) 1992-12-04
PT97858A (pt) 1992-03-31
SE9101687L (sv) 1991-12-06
GB2244709B (en) 1994-02-09
ATA112891A (de) 1994-12-15
DK106991D0 (da) 1991-06-04
FI912679A (fi) 1991-12-06
DE4118293A1 (de) 1991-12-12
MY106672A (en) 1995-07-31
JPH05117236A (ja) 1993-05-14
ITRM910387A0 (it) 1991-06-04
EP0460924A1 (en) 1991-12-11
SE9101687D0 (sv) 1991-06-04
KR920000717A (ko) 1992-01-29
AU635424B2 (en) 1993-03-18
AT399874B (de) 1995-08-25
OA09501A (en) 1992-11-15
GR910100242A (en) 1992-08-25
AU7812791A (en) 1991-12-12
CH682322A5 (tr) 1993-08-31
NL9100960A (nl) 1992-01-02
FI912679A0 (fi) 1991-06-04
IE911898A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
US5273986A (en) Cycloalkylthiazoles
SK175398A3 (en) Spiro-piperidine derivatives and their use as therapeutic agents
JPH07113027B2 (ja) K−252誘導体
PL151050B1 (en) Method for manufacturing new dichloraniline derivatives
US5254557A (en) Compound and treatment
JPS62155250A (ja) フエノキシアルキルカルボン酸およびエステル化合物,その製造方法および該化合物を含有する医薬組成物
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
JPH1180131A (ja) エチニルピリミジン誘導体
KR100192622B1 (ko) 페네타놀아민 화합물
EP1439164B1 (en) Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method
CZ282400B6 (cs) Benzpyranové sloučeniny, způsob jejich přípravy, způsob přípravy meziproduktů, farmaceutický prostředek a použití těchto sloučenin
RU2162470C2 (ru) 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения
AP251A (en) Dichloroaniline compound.
JP3616555B2 (ja) そう痒症を処置するための新規な4−アリールピペリジン誘導体
KR0175532B1 (ko) 벤조피란 및 이를 함유하는 제약 조성물
KR880002412B1 (ko) 치환된 헥사하이드로벤조 [e]인덴 및 옥타하이드로페난트렌의 제조방법
US6518282B1 (en) 4-Arylpiperidine derivatives for the treatment of pruritus
US4275219A (en) Novel process and intermediates useful in the preparation of sympathomimetic amines
US4808604A (en) N-(substituted phenyl) tetrazol-5-yl carboxamides and anti-allergic use thereof
US6124457A (en) Process and intermediates for a β3 -adrenergic receptor agonist
US5821245A (en) Use of naphthalene derivatives in treating lung carcinoma
US4757078A (en) Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents
PL158165B1 (pl) Sposób wytwarzania acylowych pochodnych hydroksypirymidyn PL PL PL PL
JP2004509897A (ja) シクロヘキシルアミン誘導体の立体選択的製造方法
US5776945A (en) 4A-aryldecahydroisoquinoline compound and medicinal use of the same